Feng Zhang (Susan Walsh/AP Images)
March 8, 2022 04:19 AM ESTUpdated 10:57 AM
Deals
Cell/Gene Tx

So, just how much are those CRISPR patents ac­tu­al­ly worth?

Jason Mast

Editor

There was a sin­gle ques­tion con­spic­u­ous­ly ab­sent in all the dis­cus­sion over last week’s CRISPR patent rul­ing (a sin­gle num­ber, re­al­ly): How much are …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Im­munol­o­gy biotech In­ma­gene to join Nas­daq through re­verse merg­er with what's left of Ike­na

A service from the Financial Times